FDA Warns of Inaccurate Results From Certain Lead Tests

Share this content:
FDA Warns of Inaccurate Results From Certain Lead Tests
FDA Warns of Inaccurate Results From Certain Lead Tests

THURSDAY, May 18, 2017 (HealthDay News) -- Lead tests made by Magellan Diagnostics may yield inaccurate results for some children and adults, U.S. health officials warned Wednesday.

Parents of children younger than 6 years old, pregnant women, and nursing mothers who have been tested for lead exposure using these tests should consult a health care provider about whether they should be retested, the officials said.

Data indicate that when all four of Magellan's lead testing systems -- LeadCare; LeadCare II; LeadCare Plus; and LeadCare Ultra -- are performed on blood drawn from a vein, they may give results that are lower than the actual level of lead in the blood.

"The FDA is concerned that Magellan lead tests that use blood drawn from a vein may provide results that are lower than the actual level of lead in the blood," Jeffrey Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health, said during a media briefing. "There is little evidence that Magellan tests using blood from a finger or heel stick are affected."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Herbal and Dietary Supplements Are Commonly Mislabeled

Herbal and Dietary Supplements Are Commonly Mislabeled

Bodybuilding products have highest mislabeling rate; many mislabeled products tied to liver injury

Alcoholic Cirrhosis Linked to Increased Admissions, Costs

Alcoholic Cirrhosis Linked to Increased Admissions, Costs

Compared with non-alcoholic cirrhosis, excess 30-day readmissions total 29.2 per 100 patients

is free, fast, and customized just for you!

Already a member?

Sign In Now »